NCT01739647View on ClinicalTrials.gov

A Single Dose Study to Assess the Safety, Effects, and Blood and Urine Drug Levels of AZD3293 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Healthy Young VolunteersHealthy Elderly Volunteers
Interventions
DRUG

AZD3293

Oral solution

DRUG

Placebo

Oral solution

Trial Locations (1)

Unknown

Research Site, Baltimore

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY